News
Chronic heart failure and hypoalbuminaemia are linked to a poor antibody response at 3 months after the third dose of the ...
A new SARS-CoV-2 variant, Nimbus or NB.1.8.1, is drawing attention due to rising transmission in parts of Asia.
CHENNAI: Dr. Danielle Beckman is a neuroscientist whose passion for studying the brain is helping to reveal how viral ...
Long COVID also known as post-acute COVID-19 syndrome or PASC refers to the lingering symptoms and health complications that ...
FDA vaccines chief Vinay Prasad limited broader use of COVID vaccines, citing reduced risk and data concerns. Read more here.
The origins of COVID-19 remain a mystery as WHO says “Cannot rule out any theory” after an inconclusive study.
The use of TNF-α inhibitors among patients with hidradenitis suppurativa did not affect seroconversion following mRNA vaccination for COVID-19.
Creating a Promising and Novel Molecule In their research, Professor Gauthier's team studied two natural molecules: betulinic ...
21h
HealthDay on MSN2023 to 2024 COVID-19 Vaccine Provided Additional EffectivenessThe 2023 to 2024 COVID-19 vaccine provided additional effectiveness against medically attended COVID-19, according to a study published online June 24 in JAMA Network Open. Ruth Link-Gelles, Ph.D., M.
FITBOOK magazine on MSN23h
Razor-like Throat Pain May Indicate New Coronavirus VariantSharp throat pain that feels like swallowing razor blades—this symptom is particularly noticeable in infections with the new ...
Rapid diagnostics continue transforming healthcare delivery worldwide, fueled by aging populations, decentralized care models, technological converge ...
Shares of Xencor, Inc. (NASDAQ:XNCR – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the eight analysts that are presently covering the stock, MarketBeat reports. One ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results